PBP3 E.COLI FULL

ZERBAXA 750 mg (500 mg and 250 mg) intravenously every 8 hours * CrCl estimated using Cockcroft-Gault formula Recommended Dosage of ZERBAXA in Adult Patients with CrCl 50 mL/min or less ( 2.2) Estimated CrCl (mL/min) *

Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia (HABP/VABP) * Used in conjunction with metronidazole 500 mg intravenously every 8 hoursД¬omplicated Intra-abdominal Infections (cIAI) *Д¬omplicated Urinary Tract Infections (cUTI), Including Pyelonephritis Recommended Dosage of ZERBAXA by Infection in Patients with Creatinine Clearance (CrCl) Greater than 50 mL/min ( 2.1) Infection

PBP3 E.COLI FULL

For doses above 1.5 g, reconstitute a second vial in the same manner as the first one, withdraw an appropriate volume (per Table 3 in the Full Prescribing Information), and add to the same infusion bag.

See Full Prescribing Information for instructions on the preparation of solutions.

Administer all doses of ZERBAXA every 8 hours by intravenous infusion over 1 hour in patients 18 years or older.

Pbp3 e.coli